Liden Hans, Karason Kristjan, Bergh Claes-Håkan, Nilsson Folke, Koul Bansi, Wiklund Lars
Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, S-413 45 Gothenburg, Sweden.
Eur J Heart Fail. 2007 May;9(5):525-30. doi: 10.1016/j.ejheart.2006.12.003. Epub 2007 Jan 25.
To study the achievability of device weaning in patients receiving left ventricular assist devices (LVADs) as a bridge to transplantation.
Eighteen consecutive patients receiving a LVAD between September 1997 and June 2002 were included in the study. During a four-month follow-up, patients were repeatedly evaluated with right heart catheterization and echocardiography and, if functional improvement was observed, studied with the device turned off. Cardiac recovery was defined as off-pump LVEF>or=40% together with a significant improvement in invasive haemodynamic measurements (CI>or=2.5 and PCWP<or=10-12 mm Hg). Patients fulfilling these criteria were considered for weaning.
Three patients fulfilled the predefined criteria for cardiac recovery and were subjected to device explantation. In one patient, a young female with acute myocarditis, the following course was uneventful. In the second patient, a male with dilated cardiomyopathy, heart failure reoccurred only a few days later. The third patient had a relapse of giant cell myocarditis and was transplanted. One patient underwent transplantation before follow-up evaluation could be performed.
In our experience, patients with severe advanced heart failure are unlikely to show significant cardiac recovery following treatment with LVAD, in contrast to previous suggestions.
研究接受左心室辅助装置(LVAD)作为移植桥梁的患者实现装置撤机的可行性。
本研究纳入了1997年9月至2002年6月期间连续接受LVAD治疗的18例患者。在为期四个月的随访期间,对患者进行反复的右心导管检查和超声心动图评估,若观察到功能改善,则在装置关闭的情况下进行研究。心脏恢复定义为非体外循环下左心室射血分数(LVEF)≥40%,同时有创血流动力学测量指标显著改善(心脏指数(CI)≥2.5且肺毛细血管楔压(PCWP)≤10 - 12 mmHg)。符合这些标准的患者考虑进行撤机。
3例患者符合预先设定的心脏恢复标准并接受了装置移除。其中1例为患有急性心肌炎的年轻女性,术后过程顺利。第2例为患有扩张型心肌病的男性,术后仅几天就再次出现心力衰竭。第3例巨细胞心肌炎复发,随后接受了移植。1例患者在随访评估前就接受了移植。
根据我们的经验,与之前的观点相反,重度晚期心力衰竭患者在接受LVAD治疗后不太可能出现显著的心脏恢复。